Fonseca-Reyes S, Escareño-Sustaita MA, Alfaro-Jacobo KF, González-Coronado AR

Language: Spanish
References: 20
Page: 88-93
PDF size: 202.57 Kb.

ABSTRACT

Antihypertensive treatment is not without harm and sometimes the balance between the prevention of cardiovascular complications and treatment associated with adverse events is not easy. Although it is commonly advised to prolong therapy for life, different publications suggest that antihypertensive medications can be reduced or be phased out in some well-selected patients whose blood pressure is well controlled over an extended period. This process is called deprescribing and consists of withdrawal of one or more problematic or unnecessary medications, supervised by a health care professional with the goal of managing polypharmacy and improving the patient's quality of life and survival. We present the case of a patient with a 9-year history of hypertension who was being treated with a combination of antihypertensives and other drugs for diabetes and dyslipidemia and who, after three years of good BP control and subsequent weight reduction, was gradually deprescribed all his medications. In his last evaluation he maintained acceptable BP and adequate metabolic profile.

REFERENCES

1. Moonen JE, Foster-Dingley JC, de Ruijter W, van derGrond J, de Craen AJ, van der Mast RC. Effect of discontinuation of antihypertensive medication on orthostatic hypotension in older persons with mild cognitive impairment: The DANTE Study Leiden. Age Ageing. 2016;45:249-255.

2. Nelson MR, Reid CM, Krum H, McNeil JJ. A systematic review of predictors of maintenance of normotension after withdrawal of antihypertensive drugs. Am J Hypertens. 2001;14:98-105.

3. Nelson MR, Reid CM, Krum H, Ryan P, Wing LM, McNeil JJ. Short-term predictors of maintenance of normotension after withdrawal of antihypertensive drugs in the second Australian National Blood Pressure Study. Am J Hypertens. 2003;16:39-45.

4. Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33:323-328.

5. Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of "deprescribing" with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80:1254-1268.

6. Pravodelov V. Thoughtful prescribing and deprescribing. Med Clin North Am. 2020;104:751-765.

7. Fravel MA, Ernst M. Drug interactions with antihypertensives. Curr Hypertens Rep. 2021;23:14.

8. Van Der Wardt V, Harrison JK, Welsh T, Conroy S, John Gladman J. Withdrawal of antihypertensive medication: a systematic review. J Hypertens. 2017;35:1742-1749.

9. Page IH. Persistence of normal blood pressure after discontinuing treatment in hypertensive patients. Circulation. 1962;25:433-436.

10. Froom J, Trilling JS, Yeh SS, Gomolin IH, Filkin AM, Grimson RC. Withdrawal of antihypertensive medications. J Am Board Fam Pract. 1997;10:249-258.

11. Sheppard JP, Benetos A, McManus RJ. Antihypertensive deprescribing in older adults: a practical guide. Curr Hypertens Rep. 2022;24:571-580.

12. Espeland MA, Whelton PK, Kostis JB, Bahnson JL, Ettinger WH, Cutler JA, et al. Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly. Arch Fam Med. 1999;8:228-236.

13. Khoong EC, Commodore-Mensah Y, Lyles CR, Fontil V. Use of self-measured blood pressure monitoring to improve hypertension equity. Curr Hypertens Rep. 2022;24:599-613.

14. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Himmelfarb CD, et al. 2017 Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: J Am Coll Cardiol. 2018;71:1269-1324.

15. Directriz para el tratamiento farmacológico de la hipertensión en adultos [Guideline for the pharmacological treatment of hypertension in adults]. Ginebra: Organización Mundial de la Salud; 2022. Licencia: CC BY-NC-SA 3.0 IGO.

16. Promoción, Prevención, Diagnóstico y Tratamiento de la Hipertensión Arterial en Primer Nivel de Atención. Guía de Práctica Clínica: Evidencias y Recomendaciones. México, CENETEC; 2021 [26/02/2021].

17. Mancia G, Reinhold K, Brunstrom, M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: J Hypertens. 2023;41:1874-2071

18. Raghunandan R, Howard K, Ilomaki J, Hilmer SN, Gnjidic D, Bell JS. Preferences for deprescribing antihypertensive medications amongst clinicians, carers and people living with dementia: a discrete choice experiment. Age Ageing. 2023;52:1-10.

19. Halli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: evaluating risks and deprescribing. Am Fam Physician. 2019;100:32-38.

20. Reeve E, Jordan V, Thompson W, Sawan M, Todd A, Gammie TM, et al. Withdrawal of antihypertensive drugs in older people. Cochrane Database Syst Rev 2020;6(6):CD012572.